France’s R&D tax credit system is the silent engine beneath every France 2030 grant: fiscal instruments that reduce the effective cost of innovation for every company operating in France, applied automatically without competition and without the 12-month wait that characterizes France 2030’s grant mechanisms. The Crédit d’Impôt Recherche (CIR), the Crédit d’Impôt Innovation (CII), and the Jeune Entreprise Innovante (JEI) status collectively cost the French treasury €8B+ per year — substantially more than many individual France 2030 grant programs — and reach 27,000+ companies annually.
Crédit d’Impôt Recherche (CIR): France’s Flagship R&D Tax Credit
The CIR is one of the world’s most generous R&D tax credit regimes — the primary reason many multinational R&D centers choose France over lower-cost European alternatives that offer no comparable fiscal benefit.
How it works:
- Rate: 30% of eligible R&D expenditure up to €100 million per year
- Rate above €100M: 5%
- Eligible costs: Researcher salaries (with social charges), equipment depreciation for R&D, patent filing costs, technology watch subscriptions, subcontracted R&D (50% at accredited organizations, 100% at public institutions)
- Claim process: Declared on annual corporate tax return (form 2069-A). No pre-approval required.
- Refund: If tax credit exceeds corporate tax owed (common for loss-making startups), excess is refunded — typically within 3 months for SMEs
- Annual treasury cost: €7.4 billion (2024 estimate)
- Companies using CIR annually: 27,000+
Numerical example: A deeptech company with 50 researchers at €80K average total employment cost has eligible R&D payroll of €4M/year. CIR credit: 30% × €4M = €1.2M/year — a permanent subsidy requiring no application, no evaluation, no waiting period.
CIR and France 2030 grants: Eligible costs claimed for CIR cannot also be included in the basis for France 2030 grants (no double-dipping). However, France 2030 grants typically cover capital expenditure while CIR focuses on personnel and operating costs — making them genuinely additive in most cases.
Crédit d’Impôt Innovation (CII): The SME Innovation Extension
The CII complements CIR for SME activities at TRL 7–9:
- Rate: 30% of eligible innovation expenditure
- Ceiling: €400,000 of eligible costs per year (maximum annual benefit: €120,000)
- Eligible companies: SMEs only (fewer than 250 employees, revenue under €50M)
- Eligible costs: External design, prototype creation, pilot installation, certification costs for first-to-market products
- Cumulation with CIR: Allowed
CII is particularly valuable for hardware deeptech companies (robotics, medical devices, advanced manufacturing) where prototype and certification phases are expensive but clearly beyond fundamental R&D.
JEI Status: Social Charge Exemption for Startups
JEI (Jeune Entreprise Innovante) provides social charge exemption on R&D employees — potentially worth €300K–€600K/year for a typical deeptech startup team:
- Eligibility: Under 8 years old, under 250 employees, independent (50%+ natural person ownership), R&D ≥ 15% of total annual expenses
- Social charge exemption: 100% of employer contributions on R&D employee salaries (ordinarily 42–45% of gross salary), up to 4.5× minimum wage
- Corporate tax: 100% exemption in first profitable year, 50% in second
See the JEI Status page for full details.
Stacking All Three: Maximum Fiscal Optimization
Year 1–3 (pre-revenue, high R&D burn):
- JEI status: Eliminates social charges → €300K–€600K/year saved immediately
- CIR: 30% of R&D costs returned as refundable tax credit → €500K–€2M/year
- CII: 30% of prototype costs for SME → Up to €120K/year
- I-Nov grant: €1M–€3M non-dilutive capital (Year 1–2)
- Bpifrance Innovation Loan: €500K–€3M low-rate debt
Year 4–7 (demonstrator phase):
- CIR on larger R&D base as team scales
- I-Démo grant: €5M–€20M for industrial demonstrator
- EIC Accelerator: €2.5M grant + €15M equity
Total public support package over 7 years: For a well-positioned deeptech company, the combination of CIR refunds, JEI social charge savings, competitive grants, and equity investments can reach €20M–€40M in public support — funding a substantial fraction of the company’s journey from concept to commercial scale.